| Literature DB >> 35365132 |
Thien Phu Do1,2, Mikala Dømgaard2, Simon Stefansen2, Espen Saxhaug Kristoffersen3, Messoud Ashina1,2, Jakob Møller Hansen4.
Abstract
BACKGROUND: A major barrier to adequate headache care is the relative lack of formal education and training of healthcare professionals. Concerted efforts should be made to pinpoint major gaps in knowledge in healthcare professionals to facilitate better educational policies in headache training. The aim of this study was to identify deficiencies and barriers in headache training among residents in neurology in Denmark.Entities:
Keywords: Barrier; Education; Headache; Medication overuse; Migraine; Residency; Tension-type headache; Training
Mesh:
Year: 2022 PMID: 35365132 PMCID: PMC8976293 DOI: 10.1186/s12909-022-03299-6
Source DB: PubMed Journal: BMC Med Educ ISSN: 1472-6920 Impact factor: 2.463
Respondent demographics
| 54 | |
|---|---|
| ● Capital Region of Denmark | 21 (39%) |
| ● Central Denmark Region | 5 (9%) |
| ● North Denmark Region | 8 (15%) |
| ● Region of Southern Denmark | 12 (22%) |
| ● Region Zealand | 8 (15%) |
| ● Introductory program | 25 (46%) |
| ● Main program | 29 (54%) |
| ● All residents | 35 (65%) |
| ○ Residents in introductory program | 11 (44%) |
| ○ Residents in main program | 24 (83%) |
A total of 54 participants across all five regions in Denmark were included in the survey. There was an approximately even distribution between residents currently enrolled in the introduction program (1st year residents) and the main program (2nd, 3rd, 4th and 5th year residents). Two-thirds had prior training in headache disorders
Fig. 1Interest in neurological sub-specializations. All respondents were asked to list neurological sub-specializations in a ranked order, 1: most interesting, 6: least interesting. The number represent how many respondents ranked the sub-specialization a specific rank, e.g., 23 respondents ranked “Cerebrovascular Diseases” at the top of their list, i.e., rank 1. “Cerebrovascular diseases” is on average ranked as the most interesting sub-specialization whereas”Headache” ranks second to last. 1: highest ranked, 6; lowest ranked
Self-reported knowledge, barriers, and challenges in headache disorders
| ● Migraine | 3.91 (0.65) | 3.76 (0.83) | 4.03 (0.42) |
| ● Tension-type headache | 3.94 (0.65) | 3.80 (0.82) | 4.07 (0.46) |
| ● Cluster headache | 3.68 (0.75) | 3.33 (0.92) | 3.89 (0.49) |
| ● Trigeminal neuralgia | 3.48 (0.84) | 3.12 (0.93) | 3.79 (0.62) |
| ● Medication overuse headache | 3.56 (0.86) | 3.28 (0.89) | 3.39 (0.77) |
| ● Post-traumatic headache | 3.15 (0.97) | 2.96 (0.98) | 3.31 (0.97) |
| ● Challenging diagnosis | 31 (57%) | 15 (60%) | 16 (55%) |
| ● Comorbidities | 23 (43%) | 9 (36%) | 14 (48%) |
| ● Patient anxiety of adverse events | 13 (23%) | 4 (16%) | 9 (31%) |
| ● Treatment failure due to adverse events | 19 (35%) | 6 (24%) | 13 (45%) |
| ● Unclear medical history | 31 (57%) | 17 (68%) | 14 (48%) |
| ● Lack of effective treatment options | 31 (57%) | 12 (48%) | 19 (66%) |
| ● No challenges | 3 (6%) | 1 (4%) | 2 (7%) |
| ● Other | 8 (15%) | 3 (12%) | 5 (17%) |
| ● Own lack of knowledge | 17 (31%) | 12 (48%) | 5 (17%) |
| ● Find headache patients difficult to diagnose and treat | 26 (48%) | 12 (48%) | 14 (48%) |
| ● Challenges in physician/patient collaboration | 17 (31%) | 6 (24%) | 11 (38%) |
| ● Insufficient consultation time | 15 (28%) | 3 (12%) | 12 (41%) |
| ● Lack of prescribed treatment efficacy | 31 (57%) | 16 (64%) | 15 (52%) |
| ● Insufficient support from other specialists | 13 (24%) | 2 (8%) | 11 (38%) |
| ● No barriers | 5 (9%) | 3 (12%) | 2 (7%) |
aScale from 1–5; 1: very bad, 5: very good. bParticipants were asked to choose one or more options
Use of guidelines, classification and tools for diagnosis and outcome assessment
| ● Guidelines from the Danish Headache Society | 2.74 (1.14) | 2.4 (1.19) | 3.03 (1.02) |
| ● Guidelines from the Danish Neurological Society | 3.15 (0.86) | 2.96 (1.02) | 3.31 (0.66) |
| ● The International Classification of Headache Disorders | 2.33 (1.08) | 2.36 (1.04) | 2.31 (1.14) |
| ● Headache diary for diagnosis | 3.31 (0.77) | 3.28 (0.84) | 3.34 (0.72) |
| ● Headache calendar for outcome assessment | 3.14 (0.93) | 2.96 (1.09) | 3.31 (0.76) |
| ● Quality of life parameters (e.g., sickness absence, reduced participation in social events) | 3.04 (0.80) | 2.88 (0.89) | 3.17 (0.71) |
Scale from 1–4; 1: never/have not heard of, 4: always
Contact and referral patterns
| ● 1–10% | 13 (24%) | 10 (40%) | 3 (10%) |
| ● 11–20% | 29 (54%) | 7 (28%) | 22 (76%) |
| ● 21–30% | 8 (15%) | 5 (20%) | 3 (10%) |
| ● 31–40% | 0 (0%) | 0 (0%) | 0 (0%) |
| ● > 40% | 4 (7%) | 3 (12%) | 1 (3%) |
| ● None | 0 (0%) | 0 (0%) | 0 (0%) |
| ● Contact from primary care for professional advice on headachea | 2.37 (1.29) | 1.89 (0.96) | 2.86 (1.36) |
| ● Collaboration with primary care for referred headache patientsb | 2.63 (0.79) | 2.60 (0.77) | 2.66 (0.83) |
| ● 1–10% | 9 (17%) | 4 (16%) | 5 (17%) |
| ● 11–20% | 35 (65%) | 14 (56%) | 21 (72%) |
| ● 21–30% | 7 (13%) | 5 (20%) | 2 (7%) |
| ● 31–40% | 1 (2%) | 1 (4%) | 0 (0%) |
| ● > 40% | 1 (2%) | 0 (0%) | 1 (3%) |
| ● Never | 1 (2%) | 1 (4%) | 0 (0%) |
| • Diagnostic uncertainty | 20 (37%) | 11 (44%) | 9 (31%) |
| • Suspicion of serious underlying cause | 2 (4%) | 2 (8%) | 0 (0%) |
| • Lack of treatment efficacy | 32 (59%) | 11 (44%) | 21 (72%) |
| • Desire/expectation of the patient | 11 (20%) | 5 (20%) | 6 (21%) |
| •Other | 8 (15%) | 5 (20%) | 3 (10%) |
| ● Short | 0 (0%) | 0 (0%) | 0 (0%) |
| ● Acceptable | 16 (30%) | 11 (44%) | 5 (17%) |
| ● Long | 21 (39%) | 8 (32%) | 13 (45%) |
| ● Unacceptably long | 8 (15%) | 2 (8%) | 6 (21%) |
| ● Do not know | 9 (17%) | 4 (16%) | 5 (21%) |
aScale from 1–5; 1: never, 5: very frequently. bScale from 1–5; 1: none/very bad, 5: very good. cParticipants could choose up to two answers. dScale from 1–5; 1: not at all, 5: to a great extent. 10 (19%) responded they did not know
Medication overuse headache
| M | |||
| ● Simple analgesics | 53 (98%) | 24 (83%) | 29 (100%) |
| ● Opioids | 32 (59%) | 12 (48%) | 20 (69%) |
| ● Migraine acute medicine (e.g., triptans) | 42 (78%) | 16 (64%) | 26 (90%) |
| ● Migraine preventive medicine (e.g., beta blockers) | 5 (9%) | 2 (8%) | 3 (10%) |
| ● Do not know | 0 (0%) | 0 (0%) | 0 (0%) |
| ● 1 day a week | 1 (2%) | 1 (4%) | 0 (0%) |
| ● 2–3 days a week | 43 (80%) | 17 (68%) | 26 (90%) |
| ● 4–5 days a week | 4 (7%) | 1 (4%) | 3 (10%) |
| ● 6 days a week | 0 (0%) | 0 (0%) | 0 (0%) |
| ● Do not know | 6 (11%) | 6 (24%) | 0 (0%) |
aScale from 1–5; 1: not at all, 5: to a great extent
Non-pharmacological interventions
| ● Patients seek advice on non-pharmacological treatment optionsa | 3.00 (1.13) | 2.84 (1.25) | 3.14 (1.03) |
| ● Feel equipped to advise patients on non-pharmacological treatment optionsb | 2.29 (0.82) | 2.08 (0.81) | 2.48 (0.76) |
| ● Acupuncture | 15 (28%) | 9 (36%) | 6 (24%) |
| ● Craniosacral therapy | 3 (6%) | 1 (4%) | 2 (7%) |
| ● Diet | 28 (52%) | 13 (52%) | 15 (52%) |
| ● Ear (daith) piercing | 1 (2%) | 0 (0%) | 1 (3%) |
| ● Exercise | 45 (83%) | 19 (76%) | 26 (90%) |
| ● Medical cannabis | 0 (0%) | 0 (0%) | 0 (0%) |
| ● Neurostimulation | 1 (2%) | 1 (4%) | 0 (0%) |
| ● Physiotherapy | 50 (93%) | 22 (88%) | 28 (97%) |
| ● Psychological treatment | 41 (76%) | 17 (68%) | 24 (83%) |
| ● Reflexology | 4 (7%) | 2 (8%) | 2 (7%) |
| ● Other | 6 (11%) | 3 (12%) | 3 (10%) |
| ● None of the above | 0 (0%) | 0 (0%) | 0 (0%) |
aScale from 1–5; 1: never, 5: very frequently. bScale from 1–5; 1: not at all, 5: to a great extent. cParticipants could choose multiple answers